Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems Collaborates with High Q Foundation on Huntington s Biomarkers

NEW YORK, April 19 (GenomeWeb News) - Proteome Systems of Sydney, Australia and the New York-based High Q Foundation announced today that they will collaborate on biomarker discovery and molecular characterization for Huntington's Disease.

 

Proteome Systems will look for changes in protein expression and modifications resulting from the malfunctioning of the Huntingtin protein. The company will then develop tests to monitor disease progression and measure outcomes of clinical trials, using its DiagnostlQ platform.

 

The company will also characterize the proteins involved in the disease to look for differences between wild-type and mutant Huntingtin proteins.

 

 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.